News
Dr. Campbell wins CTSI award
Congratulations to Dr. Campbell who has won a CTSI Integrated Pilot Grant Award for his project, "Validity, acceptability, and utility of electronic health record household linking".
Strategies to link household members in the electronic health record (EHR) offer novel opportunities to manage illnesses within the household sphere. Health information technology has been developed to link household members in EHRs for research applications, and for maternal-neonatal clinical care. However, questions of validity of EHR-generated household links, acceptability of linkage-based clinical tools, and utility of links to generate clinically actionable data, have impeded scaling of this technology to clinical applications beyond the neonatal period. Here, we propose a mixed methods project to examine the validity, acceptability, and utility of EHR-based household links to address diagnostic gaps for one of the most prevalent long-term infectious diseases affecting BMC’s patients: latent tuberculosis (TB) infection. First, we will enroll adult and pediatric patients from BMC’s TB clinic to validate EHR-based household membership using self-reported household member lists. Second, we will conduct a qualitative study to gauge acceptability of a plausible TB-focused clinical tool that uses EHR household links. Third, we will leverage a retrospective study of TB infection care access among BMC’s patients to evaluate the utility of household linkage data to reveal household TB testing gaps. Our study will generate insights that are vital to translate this novel technology to the clinical sphere, both for patients at risk of TB infection, and for the broader research and clinical community.
Collaborators include: Dr. Karen Jacobson (BU/BMC), Dr. Jessica Haberer (MGH) – co-I, Dr. Bob Horsburgh – co-I, Dr. Heather Hsu (BMC) – co-I, Dr. Helen Jenkins (BMC) – co-I, Dr. Vishakha Sabharwal (BMC) – co-I. Dr. Campbell is eager to include more collaborators as the project progresses!
Dr. Tara Bouton quoted in TIME Magazine piece
How Long Should You Isolate With COVID-19? Experts Are Split
Dr. Igor Kramnik featured in Drug Discovery News
Dr. Igor Kramnik, MD, PhD, Associate Professor of Medicine featured in Drug Discovery News: Correcting for tuberculosis susceptibility
Direct link to article: https://www.drugdiscoverynews.com/correcting-for-tuberculosis-susceptibility-15863
Spring TBIG Schedule
Please find the Spring TBIG Schedule Below. All meetings will be held on Thursdays from 1-2pm in Crosstown Center (801 Mass Ave.) Conference Room 386 (3rd Floor) as well as on Zoom at the following meeting ID:
Join via Zoom
https://bostonmedicalcenter.zoom.us/j/93318884767?pwd=KzRNQjNXak5jMVlzdEdlNUEvckVyQT09
Meeting ID: 933 1888 4767 | Passcode: tbig
Schedule/Presenters:
- Jan 18 (open to public): Professor Adrie Steyn
- Feb 15 (open to public): Dr. Simon Mendelsohn
- March 14 (internal to BU/BMC): Dr. Leo Martinez
- March 28 (open to public): Dr. Pete Dodd
- April 11 (internal to BU/BMC): Dr. Meredith Brooks
- April 25 (open to public): Dr. Brittney van de Water
- May 9 (internal to BU/BMC): Dr. Laura White
- May 23 (open to public): Dr. Rebecca Clark
- June 6 (internal to BU/BMC): Dr. Alanna Brennan
Union 2023 Recap
BU/BMC TIARA has an amazing showing at the 2023 World Conference on Lung Health. See below for a list of speakers/presentations representing our group
Researchers Find Potential Way to Tweak Immune System to Help It Fight Tuberculosis
TB is the world’s second-deadliest infectious disease, behind COVID-19. A new BU-led study shows how to turn TB-susceptible immune cells into TB-resistant ones.
Estimated costs for patients with tuberculosis in LMICs (Portnoy et al., 2023)
Check out the latest study by Portnoy et al. (2023) on the economic costs of tuberculosis treatment in low- and middle-income countries. The study delves into the often-overlooked financial burdens faced by patients, even in the presence of ostensibly free treatment. By synthesizing data from 22 national surveys conducted between 2015 and 2022, the authors estimated per-patient costs across various categories—direct medical, direct non-medical, and indirect. Notably, the findings revealed that mean direct medical costs stood at US$211, while direct non-medical and indirect costs were estimated at $512 and $530 per episode of tuberculosis, respectively. The publication underscores the urgency of addressing these economic challenges to enhance accessibility to tuberculosis diagnosis and treatment, aligning with the objectives outlined in the WHO's End TB Strategy.
Read more about this exciting work here: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(23)00369-8/fulltext
Portnoy et al. (2023) reveals economic potential of novel TB vaccines in low- and middle-income countries
Discover the potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries through a recently published modeling study in PLOS Medicine. In this study, Assistant Professor Allison Portnoy uncovers significant potential for these vaccines to drive substantial GDP gains, fostering economic development in LMICs.
Read more about this exciting work here: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004252
Providence/Boston Center for AIDS Research Awarded $9.2 Million NIH Renewal
The Providence/Boston Center for AIDS Research (Prov/Bos CFAR) has received a five-year $9.2 million award from the National Institutes of Health (NIH) to further its work promoting multi-disciplinary clinical, behavioral, translation, and basic science HIV research. Their research is particularly focused on marginalized populations including men who have sex with men (MSM), people who use substances, justice-involved persons, women, gender minorities, and at-risk youth. To achieve this goal, the Prov/Bos CFAR is committed to fostering emerging HIV investigators, expanding collaborative research, and promoting outreach dissemination and education domestically and within other resource-limited settings.
Portnoy et al. (2023) shows promise of novel TB vaccines for health equity in low-income and middle-income countries
Introducing a recently published paper in BMJ Global Health by Assistant Professor Allison Portnoy titled "The Potential Impact of Novel Tuberculosis Vaccines on Health Equity and Financial Protection in Low-Income and Middle-Income Countries."
The study reveals that these vaccines can significantly reduce financial vulnerability and improve health outcomes, particularly for lower-income groups.
Read more about the groundbreaking findings and recommendations here: https://gh.bmj.com/content/8/7/e012466.full